Research
International Progressive MS Alliance
UPDATED Public Statement – Positive Results Reported from Genentech/Roche Phase III Trial of Ocrelizumab in Primary Progressive MS
UPDATED Public Statement – Positive Results Reported from Genentech/Roche Phase III Trial of Ocrelizumab in Primary Progressive MS
© 2010 - 2024 Multiple Sclerosis Society of Ireland